Synthesis, characterization and antibacterial activities of two new Schiff bases devired from (E)-2-(((2-aminoethyl) imino) methyl) phenol (E)-2-(4-aminobut-1-enyl)-5-methylbenzamine

被引:0
作者
Sheheryar [1 ]
Farman, Saira [2 ]
Jan, Faheem [3 ]
dos Santos, Nicole Ferreira [4 ]
Khan, Asif [5 ]
Shah, Mohib Ullah [6 ]
Gul, Alia [7 ]
机构
[1] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil
[2] Abdul Wali Khan Univ Mardan, Dept Biochem, Mardan, Khyber Pakhtunk, Pakistan
[3] Minist Natl Hlth Serv Regulat & Coordinat, Natl TB Control Program, Islamabad, Pakistan
[4] Univ Fed Ceara, Ctr Agr Sci, Fortaleza, Ceara, Brazil
[5] Univ Sao Paulo, Dept Bot, Lab Phytochem, Sao Paulo, SP, Brazil
[6] Bahauddin Zakariya Univ, Fac Sci, Multan, Punjab, Pakistan
[7] Hazara Univ Mansehra, Dept Bot, Mansehra, Khyber Pakhtunk, Pakistan
来源
BIOSCIENCE RESEARCH | 2022年 / 19卷 / 02期
关键词
Schiff base; Antibacterial; FT-IR; chemical synthesis; STAPHYLOCOCCUS-AUREUS;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In the present studies two new Schiff bases ligands (E)-2-(4-aminobut-1-enyl) phenol and (E)-2-(4-aminobut-1-enyl)-5-methylaniline were synthesized. The compounds were properly characterized through FT-IR and elemental analysis and its antibacterial activities were checked against Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus, Salmonella typhimurium and Staphylococcus aureus. The Schiff base ligands were screened o for their antibacterial inhibiting potentials through Disc-diffusion method, in vitro. The results indicated that as compared to control i.e. Ciprofloxacin and Erythromycin the Schiff base have significant biological activity against E. coli, while no effective inhibition was noted for other tested bacterial strains. This research highlighted Schiff bases an effective drug against the E. coli.
引用
收藏
页码:925 / 929
页数:5
相关论文
共 13 条
[1]  
Bhat M.A., 2005, Indian J. Pharm. Sci, V67, P151
[2]   Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis [J].
Cardozo, Viviane F. ;
Lancheros, Cesar A. C. ;
Narciso, Adelia M. ;
Valereto, Elaine C. S. ;
Kobayashi, Renata K. T. ;
Seabra, Amedea B. ;
Nakazato, Gerson .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 473 (1-2) :20-29
[3]   Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics [J].
Cheng, Kui ;
Zheng, Qing-Zhong ;
Qian, Yong ;
Shi, Lei ;
Zhao, Jing ;
Zhu, Hai-Liang .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (23) :7861-7871
[4]   Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides [J].
Ghosh, Chandradhish ;
Haldar, Jayanta .
CHEMMEDCHEM, 2015, 10 (10) :1606-1624
[5]   Phytochemical and pharmacological uses of medicinal plants to treat cancer: A case study from Khyber Pakhtunkhwa, North Pakistan [J].
Khan, Asif ;
Ali, Sajid ;
Murad, Waheed ;
Hayat, Khizar ;
Siraj, Shumaila ;
Jawad, Muhammad ;
Khan, Rashid Abbas ;
Uddin, Jalal ;
Al-Harrasi, Ahmed ;
Khan, Ajmal .
JOURNAL OF ETHNOPHARMACOLOGY, 2021, 281
[6]   Discovery of novel selective inhibitors of Staphylococcus aureus β-ketoacyl acyl carrier protein synthase III [J].
Lee, Jee-Young ;
Jeong, Ki-Woong ;
Shin, Soyoung ;
Lee, Ju-Un ;
Kim, Yangmee .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 47 :261-269
[7]   Antimicrobial Peptides and Peptidomimetics - Potent Therapeutic Allies for Staphylococcal Infections [J].
Mohammad, Haroon ;
Thangamani, Shankar ;
Seleem, Mohamed N. .
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (16) :2073-2088
[8]  
Morrison L., 2020, Gastrointest Endosc Clinics, V30, P619, DOI [10.1016/j.giec.2020.06.004, DOI 10.1016/J.GIEC.2020.06.004]
[9]  
Sheheryar Zahida P., 2017, INT J BIOSCI, V10, P259, DOI DOI 10.12692/ijb/10.6.259-264
[10]   Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms [J].
Stryjewski, Martin E. ;
Graham, Donald R. ;
Wilson, Samuel E. ;
O'Riordan, William ;
Young, David ;
Lentnek, Arnold ;
Ross, Douglas P. ;
Fowler, Vance G. ;
Hopkins, Alan ;
Friedland, H. David ;
Barriere, Steven L. ;
Kitt, Michael M. ;
Corey, G. Ralph .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (11) :1683-1693